United States Steroidal Nasal Gel Market Size, Share, and COVID-19 Impact Analysis, By Formulation Type (Aqueous Gel and Non-Aqueous Gel), By Application (Allergic Rhinitis, Non-Allergic Rhinitis, Sinusitis, and Others), and United States Steroidal Nasal Gel Market Insights, Industry Trend, Forecasts to 2035

United States Steroidal Nasal Gel Market Insights Forecasts to 2035

• The USA Steroidal Nasal Gel Market Size is Expected to Grow at a CAGR of around 4.6% from 2025 to 2035.
• The United States Steroidal Nasal Gel Market Size is Expected to Hold a Significant Share by 2035.

According to a research report published by Spherical Insights & Consulting, the U.S. Steroidal Nasal Gel Market Size is Expected to hold a significant share by 2035, Growing at a CAGR of 4.6% from 2025 to 2035. The U.S. steroidal nasal gel market is growing due to the rising prevalence of allergic rhinitis and chronic sinusitis, increasing demand for effective, non-invasive drug delivery, and advancements in nasal gel formulations. Convenience, faster onset of action, and growing awareness of steroidal nasal therapies also drive adoption. Additionally, the expanding geriatric population and rising healthcare expenditure support market growth.

Market Overview

The United States steroidal nasal gel market encompasses pharmaceutical products designed to deliver corticosteroids directly to the nasal mucosa for treating allergic rhinitis, chronic sinusitis, and other inflammatory nasal conditions. These gels offer targeted therapy with improved efficacy and reduced systemic side effects compared to oral corticosteroids, positioning them as a preferred treatment option. The market is driven by the rising prevalence of respiratory allergies and sinus disorders, increasing patient preference for non-invasive drug delivery, and continuous advancements in formulation technologies that enhance bioavailability and patient compliance. Strengths of the market include rapid onset of action, ease of use, and growing acceptance among healthcare providers. Opportunities lie in expanding indications, developing novel combination therapies, and increasing awareness about respiratory health among aging populations. Government initiatives promoting healthcare access and funding for respiratory disease research further support market growth. Additionally, heightened urban pollution levels and seasonal allergy prevalence provide a fertile environment for market expansion.

Report Coverage

This research report categorizes the market for the United States steroidal nasal gel market based on various segments and regions and forecasts revenue growth and analyzes trends in each submarket. The report analyses the key growth drivers, opportunities, and challenges influencing the United States steroidal nasal gel market. Recent market developments and competitive strategies such as expansion, product launch, development, partnership, merger, and acquisition have been included to draw the competitive landscape in the market. The report strategically identifies and profiles the key market players and analyses their core competencies in each sub-segment of the United States steroidal nasal gel market.

Driving Factors

The increasing prevalence of allergic rhinitis, chronic sinusitis, and other upper respiratory conditions creates a strong demand for effective treatment options. Steroidal nasal gels offer targeted drug delivery with faster onset of action and reduced systemic side effects compared to oral medications, making them a preferred choice among patients and healthcare providers. Advancements in formulation technology, including better bioavailability and sustained release, enhance therapeutic outcomes. Additionally, the rising awareness about non-invasive and user-friendly treatment options, coupled with an expanding geriatric population prone to respiratory ailments, further propels market growth. Growing healthcare expenditure and increased focus on research and development are also significant factors driving the market. Furthermore, increasing urban pollution and seasonal allergies continue to escalate demand for steroidal nasal gels.

Restraining Factors

The potential side effects associated with prolonged steroid use include nasal irritation and systemic absorption risks. High costs of advanced formulations and limited awareness among some patient groups also hinder market growth. Additionally, the availability of alternative therapies like antihistamines and non-steroidal nasal sprays, along with stringent regulatory requirements, poses challenges.

Market Segmentation

The United States steroidal nasal gel market share is classified into formulation type and application.

• The aqueous gel segment held the highest share in 2024 and is expected to grow at a significant CAGR during the forecast period.

The United States steroidal nasal gel market is segmented by formulation type into aqueous gel and non-aqueous gel. Among these, the non-ferrous segment held the highest share in 2024 and is expected to grow at a significant CAGR during the forecast period. This is due to its superior ease of application, better patient comfort, and faster drug absorption. Aqueous gels are preferred for their non-greasy texture and reduced nasal irritation compared to non-aqueous gels. This formulation also supports enhanced bioavailability, making it the favored choice among healthcare providers and patients alike.

• The allergic rhinitis segment held a substantial share in 2024 and is expected to grow at a significant CAGR during the forecast period.

The United States steroidal nasal gel market is segmented by application into allergic rhinitis, non-allergic rhinitis, sinusitis, and others. Among these, the allergic rhinitis segment held a substantial share in 2024 and is expected to grow at a significant CAGR during the forecast period. This is attributed to the high prevalence of this condition and the effectiveness of steroidal nasal gels in reducing inflammation and symptoms. The growing incidence of seasonal and perennial allergies drives demand, making allergic rhinitis the primary application segment, surpassing non-allergic rhinitis, sinusitis, and other uses in market share.

Competitive Analysis:

The report offers the appropriate analysis of the key organizations/companies involved within the United States steroidal nasal gel market, along with a comparative evaluation primarily based on their product offering, business overviews, geographic presence, enterprise strategies, segment market share, and SWOT analysis. The report also provides an elaborate analysis focusing on the current news and developments of the companies, which includes product development, innovations, joint ventures, partnerships, mergers & acquisitions, strategic alliances, and others. This allows for the evaluation of the overall competition within the market.

List of Key Companies

• Bayer HealthCare Pharmaceuticals Inc.
• Akorn Operating Company LLC
• Catalent Pharma Solutions
• NeilMed Pharmaceuticals
• Formulated Solutions, LLC
• Vivimed Labs USA, Inc.
• Natesto, Neurelis, Inc.
• Church & Dwight
• Bausch Health
• AptarGroup
• Allegiant Health
• Medtronic
• Guna Inc.
• AstraZeneca
• Others

Key Target Audience

• Market Players
• Investors
• End-users
• Government Authorities 
• Consulting and Research Firm
• Venture capitalists
• Value-Added Resellers (VARs)

Market Segment

This study forecasts revenue at the USA, regional, and country levels from 2020 to 2035. Spherical Insights has segmented the United States steroidal nasal gel market based on the below-mentioned segments:

U.S. Steroidal Nasal Gel Market, By Formulation Type

• Aqueous Gel
• Non-Aqueous Gel

U.S. Steroidal Nasal Gel Market, By Application

• Allergic Rhinitis
• Non-Allergic Rhinitis
• Sinusitis
• Others